Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Feb 27;12(2):e0172753.
doi: 10.1371/journal.pone.0172753. eCollection 2017.

Affordability of medicines in the European Union

Tomasz Zaprutko  1 , Dorota Kopciuch  1 , Krzysztof Kus  1 , Piotr Merks  2 , Monika Nowicka  3 , Izabela Augustyniak  3 , Elżbieta Nowakowska  1
Affiliations

Affordability of medicines in the European Union

Tomasz Zaprutko et al. PLoS One. .

Abstract

Background: Medications and their prices are key issues for healthcare. Although access to medicines at affordable prices had been specified as a key objective of the European Health Policy, it seems that these goals have not been achieved. Therefore, we attempted an evaluation of affordability of selected medicines at full prices.

Methods: The analysis concerned 2012 and was conducted between 2013 and 2015 in all the European Union (EU) countries divided into 3 groups depending on the date of their accession to the EU. Finally, we considered 9 originators used in the treatment of schizophrenia and multiple sclerosis. Information on drug prices were collected from pharmacies. Participation in the study was voluntary and anonymous in order to avoid accusations of advertising. To evaluate affordability, several factors were used (e.g. minimum earnings and Gini coefficient). Due to unavailability in some countries, the exact number of analyzed medicines varies.

Results: Drug prices vary significantly between EU Member States. Almost eleven fold difference was observed between Germany (EUR 1451.17) and Croatia (EUR 132.77) in relation to Interferone beta-1a 22 μg. Generally, prices were the highest in Germany. The cheapest drugs were found in various countries but never in the poorest ones like Bulgaria or Romania. Discrepancies in wages were observed too (the smallest minimum wage was EUR 138.00 in Bulgaria and the highest EUR 1801.00 in Luxembourg). Full price of olanzapine 5mg, however, was higher in Bulgaria (EUR 64.53) than, for instance, in Belgium (EUR 37.26).

Conclusions: Analyzed medications are still unaffordable for many citizens of the EU. Besides, access to medicines is also impaired e.g. due to parallel trade. Unaffordability of medications may lead to the patients' non-compliance and therefore to increased direct and indirect costs of treatment. Common European solutions are needed to achieve a real affordability and accessibility of medications.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have no conflicts of interest to declare.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Mhlanga B, Suleman F. Price, availability and affordability of medicines. Afr J Prm Health Care Fam Med 2014; - PMC - PubMed
    1. Vogler S, Kilpatrick K, Babar Z. Analysis of Medicine Prices in New Zealand and 16 European Countries. Value in Health 2015;484–492. 10.1016/j.jval.2015.01.003 - DOI - PubMed
    1. Xi X, Li W, Li J, Zhu X, Fu C, Wei X, et al. A survey of the availability, process and affordability of essentials medicines in Jiangsu Province, China. BMC 2015;15:345 - PMC - PubMed
    1. World Health Organization. WHO Guideline on Country Pharmaceutical Pricing Policies. Geneva, Switzerland: WHO, 2013. - PubMed
    1. Kanavos P, Vandoros S, Irwin R, Nicod E, Cassod M. European Parliament’s Committee on Environment, ed. Differences in costs of and access to pharmaceutical products in the EU. Brussels, Belgium: European Parliament, 2011.

Substances